Evaluating the Impact of Freespira on Panic Disorder Patients’ Health Outcomes and Healthcare Costs within the Allegheny Health Network
Autor: | Alicia Kaplan, Anthony P. Mannarino, P V Nickell |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
business.industry Panic disorder Public health 05 social sciences Panic Pharmacy Emergency department Panic Disorder Severity Scale medicine.disease 050105 experimental psychology 03 medical and health sciences 0302 clinical medicine Neuropsychology and Physiological Psychology Internal medicine Health care Hyperventilation medicine 0501 psychology and cognitive sciences medicine.symptom business 030217 neurology & neurosurgery Applied Psychology |
Zdroj: | Applied Psychophysiology and Biofeedback. 45:175-181 |
ISSN: | 1573-3270 1090-0586 |
DOI: | 10.1007/s10484-020-09465-0 |
Popis: | Panic disorder (PD) is a debilitating condition that drives medical spending at least twice as high as medically matched controls. Excessive utilization of healthcare resources comes from emergency department (ED), medications, diagnostic testing, and physician visits. Freespira is an FDA-cleared digital therapeutic that treats PD and panic attacks (PA) by correcting underlying abnormal respiratory physiology. Efficacy of Freespira has been established in prior studies. This paper reports on a quality improvement program that investigated whether treating PD patients with Freespira would reduce medical costs and improve outcomes over 12-months. Panic symptoms were assessed using the Panic Disorder Severity Scale (PDSS). Pre-and post-treatment insurance claims determined costs. At baseline, mean Clinician Global Impression (CGI-S) was 4.4 (moderately/markedly ill), mean PDSS was 14.4 and mean PA frequency/week was 2 (range 0–5). Immediately post-treatment (week 5) mean CGI-S, PDSS and weekly PA frequency declined to 2.8 (borderline/mildly ill, 4.9 (remission) and 0.2 (range 0–2) respectively, p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |